Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON-block in Chronic Migraine (DHC-GON-1)
2016-000676-15Phase 2Terminated
- Sponsor
- Dansk Hovedpinecenter
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of betamethasone in chronic migraine (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Number of migraine days. Started Mar 2016; status: terminated.
02
Drugs
betamethasone
03
Conditions
chronic migraine
Beyond the preview
Go deeper on 2016-000676-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000676-15.